Biolevox(TM) intraarticular injections
Products
Information
Biolevox(TM) HA 2.2% is a hyaluronic acid (HA) gel designed for a three intra-articular injection into the osteoarthritis (OA) affected in order to ameliorate symptoms of the osteoarthritis (OA) in synovial joint.Designed HA-based gel contains 44 mg of hyaluronate in 2 mL pre-filled syringe. The combination of high concentration of hyaluronate and optimally high molecular weight creates gel characterized with optimally high viscosity and elasticity . With those properties Biolevox(TM) HA 2.2% is an ideal solution for a triple intra-articular injection viscosupplementation therapy.
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
Poland
All categories
Biopharmaceutical ProductsFinished Dosage FormsInjectablesPackaging Materials and EquipmentMedical Devices and Medical PackagingRegenerative MedicineProducts
Main Categories
Biopharmaceutical ProductsFinished Dosage FormsPackaging Materials and Equipment
